Viking Global Opportunities GP LLC (CIK 0001629476)

Latest company ownership

Shares held
30,993,708
Last filed at
Nov 13, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Shares held
18,555,375
Last filed at
Jul 1, 2025
Confidence Score
47.9
2025Q4
Confidence Score History
2019Q2 2025Q4
FIGS - FIGS, Inc.
Role: 10% Owner
Shares held
14,742,689
Last filed at
Sep 3, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
12,884,307
Last filed at
Jun 26, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4
Shares held
4,247,914
Last filed at
Jan 5, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
3,943,284
Last filed at
Dec 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
RLYB - Rallybio Corp
Role: 10% Owner
Shares held
3,333,388
Last filed at
Nov 17, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
1,850,940
Last filed at
Sep 9, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4
Shares held
298,205
Last filed at
Mar 22, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
102,864
Last filed at
Oct 9, 2025
Confidence Score
23.8
2025Q4
Confidence Score History
2025Q4 2025Q4
APG - APi Group Corp
Role: 10% Owner
Shares held
17,088
Last filed at
Jan 4, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 7, 2025 Oct 9, 2025 Inhibrx Biosciences, Inc. 10% Owner Sell 15.0 -350,000 -19.58% ✗ $11.3M
Jun 27, 2025 Jul 1, 2025 BridgeBio Pharma, Inc. 10% Owner Sell 15.0 -3,500,000 -15.87% ✗ $154M
Jan 31, 2025 Jan 31, 2025 BridgeBio Pharma, Inc. 10% Owner Sell 15.0 -3,065,616 -12.20% ✗ $107M
Jun 17, 2024 Jun 18, 2024 APi Group Corp 10% Owner Sell 15.0 -1,951,782 -100.00% ✗ $74.5M
Mar 5, 2024 Mar 7, 2024 APi Group Corp 10% Owner Sell 15.0 -3,038,617 -60.89% ✗ $104.1M
Feb 28, 2024 Mar 1, 2024 APi Group Corp 10% Owner Sell 15.0 -4,065,039 -44.89% ✗ $150M
Jan 4, 2024 Jan 5, 2024 4D Molecular Therapeutics, Inc. 10% Owner Sell 15.0 -540,000 -11.28% ✗ $10.5M
Jan 2, 2024 Jan 4, 2024 APi Group Corp 10% Owner Sell 15.0 -6,500,000 -18.90% ✗ $203.5M
Jul 18, 2023 Jul 19, 2023 BridgeBio Pharma, Inc. 10% Owner Sell 15.0 -1,500,000 -5.63% ✗ $52.5M
Jun 22, 2023 Jun 26, 2023 Roivant Sciences Ltd. 10% Owner Sell 15.0 -13,000,000 -14.73% ✗ $128.7M
May 9, 2023 May 11, 2023 4D Molecular Therapeutics, Inc. 10% Owner Buy 100.0 +850,000 21.59% ✗ $13.6M
Sep 8, 2022 Sep 9, 2022 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 15.0 -1,400,000 -2.66% ✗ $41.7M
Mar 18, 2022 Mar 22, 2022 PROCEPT BioRobotics Corp 10% Owner Sell 15.0 -1,249,000 -25.45% ✗ $37.3M
Jan 11, 2022 Jan 13, 2022 Amylyx Pharmaceuticals, Inc. 10% Owner Buy 100.0 +2,300,000 100.00% ✗ $43.7M
Sep 17, 2021 Sep 21, 2021 PROCEPT BioRobotics Corp 10% Owner Buy 100.0 +400,000 100.00% ✗ $14M
Sep 2, 2021 Sep 3, 2021 FIGS, Inc. 10% Owner Sell 16.3 -200,000 -1.34% ✗ $9.4M
Jul 29, 2021 Aug 2, 2021 Rallybio Corp 10% Owner Buy 100.0 +806,000 23.78% ✗ $10.5M
Dec 15, 2020 Dec 17, 2020 4D Molecular Therapeutics, Inc. 10% Owner Buy 100.0 +1,100,000 38.76% ✗ $25.3M
Dec 1, 2020 Dec 3, 2020 Zentalis Pharmaceuticals, Inc. 10% Owner Sell 15.0 -500,000 -11.25% ✗ $25.3M
Nov 11, 2020 Nov 13, 2020 Adaptive Biotechnologies Corp 10% Owner Sell 15.0 -2,500,000 -7.46% ✗ $123.8M
Apr 7, 2020 Apr 8, 2020 Zentalis Pharmaceuticals, Inc. 10% Owner Buy 100.0 +725,000 19.50% ✗ $13.1M
Jan 28, 2020 Jan 30, 2020 Adaptive Biotechnologies Corp 10% Owner Sell 15.0 -4,912,899 -12.79% ✗ $122.7M
Jul 1, 2019 Jul 2, 2019 Adaptive Biotechnologies Corp 10% Owner Buy 100.0 +250,000 17.54% ✗ $5M
Jun 27, 2019 Jun 28, 2019 BridgeBio Pharma, Inc. 10% Owner Buy 100.0 +4,705,900 21.47% ✗ $80M